Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Determinants of "Fitness" for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients

Abby Statler, PhDMPH, Brian P. Hobbs, PhD, Tomas Radivoyevitch, PhD, Caitlin Siebenaller, PharmD, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Aziz Nazha, MD, Bhumika J. Patel, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS

Blood (2019) 134 (Supplement_1): 3836.

https://doi.org/10.1182/blood-2019-128853

Published: 2019

Journal Articles

Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation

Blood (2019) 134 (Supplement_1): 512.

https://doi.org/10.1182/blood-2019-125937

Published: 2019

Journal Articles

Increased Mortality and Bleeding in a Large Cohort of Patients on Heparin Anticoagulation Therapy with Discordant Anti-Factor Xa Activity and Activated Partial Thromboplastin Time (PTT); Implications for Clinical Management

Saurabh Gombar, MD PhD, Derek Boothroyd, PhD, Anandi Krishnan, PhD, Husham Sharifi, MD, Joe Hsu, MD, James Zehnder, MD

Blood (2019) 134 (Supplement_1): 712.

https://doi.org/10.1182/blood-2019-132112

Published: 2019

Journal Articles

Analysis of Factors Predictive of Risk of Transformation and Time to Transformation in Patients (pts) with Mantle Cell Lymphoma - Cohort Study of 369 Patients

Blood (2019) 134 (Supplement_1): 1526.

https://doi.org/10.1182/blood-2019-125936

Published: 2019

Journal Articles

Starting T Cell and Cell Product Phenotype Are Associated with Durable Remission of Leukemia Following CD19 CAR-T Cell Immunotherapy

Rebecca Gardner, MD, Olivia Finney, PhD, Hannah Brakke, MS, Stephanie Rhea, BS, Roxana Hicks, BS, Danielle Doolittle, Marisa Lopez, Rimas J Orentas, PhD, Daniel Li, PhD, Michael C. Jensen, MD

Blood (2018) 132 (Supplement 1): 4022.

https://doi.org/10.1182/blood-2018-99-117493

Published: 2018

Journal Articles

Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation

David M. Cordas Dos Santos, Rima M. Saliba, PhD, Romil Patel, BA, Qaiser Bashir, MD MBBS, Chitra Hosing, MD, Partow Kebriaei, MD, Issa F. Khouri, Yago Nieto, MD PhD, Uday Popat, MD, Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MD MSc, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MD PhD, Richard E Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2018) 132 (Supplement 1): 2144.

https://doi.org/10.1182/blood-2018-99-114200

Published: 2018

Journal Articles

The Prognostic Impact of Minimal Residual Disease on Risk of Progression and Progression Free Survival in Acute Myeloid Leukemia

Betul Oran, MDMS, Rima M. Saliba, PhD, Jeffrey L. Jorgensen, MD PhD, Mithun Vinod Shah, MD PhD, David Costa Marin, MD, Sa A. Wang, MD, Sairah Ahmed, MD, Amin M. Alousi, MD, Borje S Andersson, MDPhD, Qaiser Bashir, MD MBBS, Stefan O. Ciurea, Katy Rezvani, MD PhD, Uday Popat, MD, Gabriela Rondon, MD, Partow Kebriaei, MD, Elizabeth J Shpall, MD, Richard E. Champlin, MD

Blood (2017) 130 (Supplement 1): 2031.

https://doi.org/10.1182/blood.V130.Suppl_1.2031.2031

Published: 2017

Journal Articles

Sequential Stratification Prognostic Score for Patients with Intermediate-Risk Myelodysplastic Syndrome

Christopher B Benton, MD, Maliha Khan, MD, Graciela Nogueras González, Aziz Nazha, MD, Jin Piao, Jing Ning, PhD, Fleur M. Aung, MD, Elias J. Jabbour, MD, Tapan Kadia, MD, Gautam Borthakur, MD, Farhad Ravandi, MBBS, Rami S. Komrokji, MD, David P. Steensma, MD, Amy E. DeZern, MD, Gail J. Roboz, MD, Mikkael A. Sekeres, MD MS, Michael Andreeff, MD PhD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD

Blood (2017) 130 (Supplement 1): 4265.

https://doi.org/10.1182/blood.V130.Suppl_1.4265.4265

Published: 2017

Journal Articles

Graft Failure Post Allogeneic Stem Cell Transplant: Conditioning Regimen Improves Engraftment and Survival

Blood (2017) 130 (Supplement 1): 3267.

https://doi.org/10.1182/blood.V130.Suppl_1.3267.3267

Published: 2017

Journal Articles

Levels of Protein S and Risk of Thromboembolism

Samip R Master, MD, John Hedgepeth, McLarty Jerry, Richard Preston Mansour, MD

Blood (2017) 130 (Supplement 1): 4899.

https://doi.org/10.1182/blood.V130.Suppl_1.4899.4899

Published: 2017

Journal Articles

Doses of Total Nucleated Cells and Activated T-Cells Transplanted Influence Survival and Graft Versus Host Disease Among AML and MDS Recipients of Reduced-Intensity Mobilized Peripheral Blood Allografts

Daniel R Richardson, MD, Qiuhong Zhao, MS, Rhonda Kitzler, MS, Patrick Elder, MS, Gerard Lozanski, MD, Leslie A. Andritsos, MD, Don M Benson, MD PhD, William Blum, MD, Yvonne A Efebera, MD MPH, Samantha Jaglowski, MD MPH, Rebecca B Klisovic, MD, Sam Penza, MD, Sumithra Vasu, MBBS, Steven M Devine, MD

Blood (2016) 128 (22): 4598.

https://doi.org/10.1182/blood.V128.22.4598.4598

Published: 2016

Journal Articles

Splenomegaly Negatively Affects Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplantation

Yoshimitsu Shimomura, MD, Yuichiro Ono, MD, Satoshi Yoshioka, MD, PhD, Nobuhiro Hiramoto, MD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2016) 128 (22): 2198.

https://doi.org/10.1182/blood.V128.22.2198.2198

Published: 2016

Journal Articles

Clinicopathological Features and Outcomes of Progression for Chronic Lymphocytic Leukaemia (CLL) Treated with the BCL2 Inhibitor Venetoclax

Thomas E Lew, Mary Ann Anderson, MBBS, Constantine S. Tam, MBBS, David C.S. Huang, MBBS, MRCP, PhD, Surender Juneja, MD FRCPA, David A Westerman, MBBS, FRACP, FRCPA, John F Seymour, Andrew W. Roberts, MBBS, PhD

Blood (2016) 128 (22): 3223.

https://doi.org/10.1182/blood.V128.22.3223.3223

Published: 2016

Journal Articles

Hematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning in Older Patients with Myelodysplastic Syndromes

Orhan Kemal Yucel, MD, Rima M Saliba, PhD, Gabriela Rondon, MD, Sairah Ahmed, MD, Amin Alousi, MD, Qaiser Bashir, MD, Stefan O. Ciurea, MD, Uday R. Popat, MD, David Marin, MD, Katy Rezvani, MD PhD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Betul Oran, MD

Blood (2016) 128 (22): 5847.

https://doi.org/10.1182/blood.V128.22.5847.5847

Published: 2016

Journal Articles

Diagnostic and Prognostic Value of Factor VIII Binding Antibodies in Acquired Hemophilia A: Data from the GTH-AH 01/2010 Study

Andreas Tiede, MD PhD, Sonja Werwitzke, MD PhD, Ulrich Geisen, MD PhD, Ulrike Nowak-Göttl, MD PhD, Hermann Eichler, MD PhD, Bernhard Stephan, MD, Ute Scholz, MD, Holstein Katharina, MD, Robert Klamroth, Paul Knöbl, MD PhD, Angela Huth-Kühne, MD, Barbara Bomke, MD

Blood (2015) 126 (23): 3515.

https://doi.org/10.1182/blood.V126.23.3515.3515

Published: 2015

Journal Articles

Decision-Tree Algorithm Optimize Hematopoietic Progenitor Cell-Based Prediction in Peripheral Blood Stem Cell Mobilization

Chia-Yun Wu, Tzeon-Jye Chiou, MD, Chun-Yu Liu, Feng-Chang Lin, Jeong-Shi Lin, Man-Hsin Hung, Liang-Tsai Hsiao, Jyh-Pyng Gau, MD, Jin-Hwang Liu, MD PhD, Hsiu-Ju Yen, Giun-Yi Hung, MD, Hui-Chi Hsu, Cheng-Hwai Tzeng, Muh-Hwa Yang, Po-Min Chen, Yuan-Bin Yu

Blood (2015) 126 (23): 1903.

https://doi.org/10.1182/blood.V126.23.1903.1903

Published: 2015

Journal Articles

Gastrointestinal Acuity Score (GAS): A Comprehensive Risk Score Incorporating Histologic Grade and Clinical Factors to Predict Need for Second Line Therapy, Non-Relapse Mortality, and Overall Survival in Lower Gastrointestinal Graft Vs. Host Disease

Jin S. Im, MD PhD, Rima M Saliba, PhD, Susan C Abraham, MD, Asif Rashid, MD, William Ross, MD, Yago Nieto, MD PhD, Elizabeth J. Shpall, MD, Betul Oran, MD, Amanda Olson, Sairah Ahmed, MD, Uday R. Popat, MD, Gabriela Rondon, MD, Muzaffar H. Qazilbash, MD, Nina Shah, MD, Richard E. Champlin, MD, Amin M. Alousi, MD

Blood (2015) 126 (23): 3128.

https://doi.org/10.1182/blood.V126.23.3128.3128

Published: 2015

Journal Articles

CD8 Cell Dose in Peripheral Blood Stem-Cell Grafts Correlates with Relapse and Survival after Reduced Intensity Allogeneic Stem-Cell Transplantation

Ran Reshef, MD, Austin P. Huffman, BA, Amy Gao, BA, Mary Sell, BS MT(ASCP), Marlise R. Luskin, MD, Selina M. Luger, MD, Alison Wakoff Loren, MDMS, Elizabeth O. Hexner, MD, Sunita Dwivedy Nasta, MD, Noelle V. Frey, MDMS, Saar I. Gill, MD PhD, James Mangan, MD PhD, Lee P. Richman, BA, Taku Kambayashi, MDPhD, Edward A. Stadtmauer, MD, Robert H. Vonderheide, MDDPhil, David L. Porter, MD

Blood (2014) 124 (21): 1260.

https://doi.org/10.1182/blood.V124.21.1260.1260

Published: 2014

Journal Articles

Analysis of (δβ) 0 Thalassemia and HPFH Deletions Suggest a Hierarchy of Cis-Acting Elements Regulating Fetal Hemoglobin Gene Expression.

Heather L Edward, BA, Tasha Morrison, MPH,BA, Jacqueline N Milton, MS, Hong-yuan Luo, MB, PhD, Lance Davis, MD, Bernard G Forget, MD, Martin H. Steinberg, MD, David H.K. Chui, MD

Blood (2014) 124 (21): 54.

https://doi.org/10.1182/blood.V124.21.54.54

Published: 2014

Journal Articles

An International Data Set for the Study of Chronic Myelomonocytic Leukemia (CMML) Validates Modern Prognostic Scoring Systems and Demonstrates a Critical Need for Novel Prognostication Strategies

Blood (2014) 124 (21): 530.

https://doi.org/10.1182/blood.V124.21.530.530

Published: 2014

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Determinants of "Fitness" for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients

Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation

Increased Mortality and Bleeding in a Large Cohort of Patients on Heparin Anticoagulation Therapy with Discordant Anti-Factor Xa Activity and Activated Partial Thromboplastin Time (PTT); Implications for Clinical Management

Analysis of Factors Predictive of Risk of Transformation and Time to Transformation in Patients (pts) with Mantle Cell Lymphoma - Cohort Study of 369 Patients

Starting T Cell and Cell Product Phenotype Are Associated with Durable Remission of Leukemia Following CD19 CAR-T Cell Immunotherapy

Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation

The Prognostic Impact of Minimal Residual Disease on Risk of Progression and Progression Free Survival in Acute Myeloid Leukemia

Sequential Stratification Prognostic Score for Patients with Intermediate-Risk Myelodysplastic Syndrome

Graft Failure Post Allogeneic Stem Cell Transplant: Conditioning Regimen Improves Engraftment and Survival

Levels of Protein S and Risk of Thromboembolism

Doses of Total Nucleated Cells and Activated T-Cells Transplanted Influence Survival and Graft Versus Host Disease Among AML and MDS Recipients of Reduced-Intensity Mobilized Peripheral Blood Allografts

Splenomegaly Negatively Affects Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplantation

Clinicopathological Features and Outcomes of Progression for Chronic Lymphocytic Leukaemia (CLL) Treated with the BCL2 Inhibitor Venetoclax

Hematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning in Older Patients with Myelodysplastic Syndromes

Diagnostic and Prognostic Value of Factor VIII Binding Antibodies in Acquired Hemophilia A: Data from the GTH-AH 01/2010 Study

Decision-Tree Algorithm Optimize Hematopoietic Progenitor Cell-Based Prediction in Peripheral Blood Stem Cell Mobilization

Gastrointestinal Acuity Score (GAS): A Comprehensive Risk Score Incorporating Histologic Grade and Clinical Factors to Predict Need for Second Line Therapy, Non-Relapse Mortality, and Overall Survival in Lower Gastrointestinal Graft Vs. Host Disease

CD8 Cell Dose in Peripheral Blood Stem-Cell Grafts Correlates with Relapse and Survival after Reduced Intensity Allogeneic Stem-Cell Transplantation

Analysis of (δβ) 0 Thalassemia and HPFH Deletions Suggest a Hierarchy of Cis-Acting Elements Regulating Fetal Hemoglobin Gene Expression.

An International Data Set for the Study of Chronic Myelomonocytic Leukemia (CMML) Validates Modern Prognostic Scoring Systems and Demonstrates a Critical Need for Novel Prognostication Strategies

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only